We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information
Learn more about colorectal and liver cancer, answer a few brief questions to find out if you may qualify for a study, review a list of clinical studies that are now enrolling, and find other resources for support as you consider your next steps with colorectal or liver cancer.
You may qualify for a clinical trial.
divider
Jump to Studies
Thank You for Considering a Clinical Trial
We have several clinical trials that are currently recruiting to evaluate experimental medications for gastrointestinal (GI) cancers. See if there are clinical trials that might be right for you.
Below you will find clinical trials that are either currently recruiting patients (noted as Recruiting) or will be starting to recruit patients soon (noted as Not Yet Recruiting).
Here are some options for you to find more information:
divider
A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors
A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer
A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumors
A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer
divider
divider
Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer.
Learn MoreColorectal cancer, or CRC, is a cancer that forms in the tissues of the colon or rectum, which are part of the body’s digestive or gastrointestinal (GI) system.
Bristol Myers Squibb is not affiliated with nor endorses any of the listed organizations. The information/links provided by Bristol Myers Squibb are meant for informational purposes only and are not meant to replace a physician's medical advice or imply endorsement.
divider
We strongly recommend you contact BMS to report Side Effects (Adverse Events)
Side Effects (Adverse Events) and other reportable events are defined here
Report Side Effects (Adverse Events) or Product Quality Complaints: Medical Information